Lopressor: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 26: | Line 26: | ||
===[[Lopressor dose adjustments#Labor and Delivery|Labor and Delivery]]=== | ===[[Lopressor dose adjustments#Labor and Delivery|Labor and Delivery]]=== | ||
===[[Lopressor dose adjustments#Nursing Mothers|Nursing Mothers]]=== | ===[[Lopressor dose adjustments#Nursing Mothers|Nursing Mothers]]=== | ||
===[[Lopressor dose adjustments#Pediatric Use|Pediatric Use]]=== | ===[[Lopressor dose adjustments#Pediatric Use|Pediatric Use]]=== | ||
===[[Lopressor dose adjustments#Geriatric Use|Geriatric Use]]=== | ===[[Lopressor dose adjustments#Geriatric Use|Geriatric Use]]=== | ||
===[[Lopressor dose adjustments#Gender|Gender]]=== | ===[[Lopressor dose adjustments#Gender|Gender]]=== | ||
===[[Lopressor dose adjustments#Race|Race]]=== | ===[[Lopressor dose adjustments#Race|Race]]=== | ||
===[[Lopressor dose adjustments#Renal Impairment|Renal Impairment]]=== | ===[[Lopressor dose adjustments#Renal Impairment|Renal Impairment]]=== | ||
===[[Lopressor dose adjustments#Hepatic Impairment|Hepatic Impairment]]=== | ===[[Lopressor dose adjustments#Hepatic Impairment|Hepatic Impairment]]=== | ||
===[[Lopressor dose adjustments#Females of Reproductive Potential and Males|Females of Reproductive Potential and Males]]=== | ===[[Lopressor dose adjustments#Females of Reproductive Potential and Males|Females of Reproductive Potential and Males]]=== | ||
===[[Lopressor dose adjustments#Immunocompromised Patients|Immunocompromised Patients]]=== | ===[[Lopressor dose adjustments#Immunocompromised Patients|Immunocompromised Patients]]=== | ||
==[[Lopressor FDA-labeled indications|FDA-Labeled Indications]]== | ==[[Lopressor FDA-labeled indications|FDA-Labeled Indications]]== | ||
==[[Lopressor Off-label use|Off-Label Use]]== | ==[[Lopressor Off-label use|Off-Label Use]]== | ||
==[[Lopressor contraindications|Contraindications]]== | |||
Line 68: | Line 57: | ||
==[[Lopressor dosage forms and strengths|Dosage Forms and Strengths]]== | ==[[Lopressor dosage forms and strengths|Dosage Forms and Strengths]]== | ||
==[[Lopressor indications and usage|Indications and Usage]]== | ==[[Lopressor indications and usage|Indications and Usage]]== | ||
==[[Lopressor warnings and precautions|Warnings and Precautions]]== | ==[[Lopressor warnings and precautions|Warnings and Precautions]]== | ||
==[[Lopressor adverse reactions|Adverse Reactions]]== | ==[[Lopressor adverse reactions|Adverse Reactions]]== |
Revision as of 16:05, 17 March 2014
Clinical data | |
---|---|
Trade names | Lopressor, Toprol-xl |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682864 |
[[Regulation of therapeutic goods |Template:Engvar data]] |
|
Pregnancy category | |
Routes of administration | Oral, IV |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 12% |
Metabolism | Hepatic via CYP2D6, CYP3A4 |
Elimination half-life | 3-7 hours |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C15H25NO3 |
Molar mass | 267.364 g/mol |
3D model (JSmol) | |
Melting point | 120 °C (248 °F) |
| |
| |
(verify) |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
For information about metoprolol, click here.
Disclaimer
Black Box Warning
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Off-Label Use and Dosage (Adult)
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
Off-Label Use and Dosage (Pediatric)
Dose Adjustments
Pregnancy
Labor and Delivery
Nursing Mothers
Pediatric Use
Geriatric Use
Gender
Race
Renal Impairment
Hepatic Impairment
Females of Reproductive Potential and Males
Immunocompromised Patients
FDA-Labeled Indications
Off-Label Use
Contraindications
Dosage Forms and Strengths
Indications and Usage
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Mechanism of Action
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Pill Images and Characteristics
Price
Look-Alike Drug Names
Categories:
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles with non-default infobox title
- Antianginals
- Antiarrhythmic agents
- Antihypertensive agents
- Antimigraine drugs
- Beta blockers
- Cardiovascular Drugs